| Director Dealings Summary - Week Ended February 20 | ||||||||||||
| Company | Name | Position | Buy or Sell | Number of Shares | Resulting Holding | *Note | ||||||
| 600 Group | Nigel Rogers | CEO | Buy | 150,000 | 1.5 million | Day after issuing first tranche of loan notes | ||||||
| Amati VCT | Charles Pinney | Director | Sold | 6,540 | 29,377 | |||||||
| ARM Holdings | Tom Lantzsch | EVP Strategy | Sold | 54,201 | 48,892 | Week after ARM raised dividend & posted increased profit for 2014 | ||||||
| Anglo American | John Parker | Chairman | Buy | 8,240 | Undisclosed | 3 days after reporting drop in earnings | ||||||
| Ashley House | Stephen Minion | Deputy Chair | Buy | 150,000 | 4.1 million | |||||||
| Ashley House | Christopher Lyons | Chairman | Buy | 100,000 | 176,500 | |||||||
| Ashley House | Nigel Croxford | Construction Director | Buy | 100,000 | 901,530 | |||||||
| Ashley House | Antony Walters | CEO | Buy | 300,000 | 579,000 | |||||||
| Ashley House | Jonathan Holmes | Director | Buy | 140,000 | 2.1 million | |||||||
| Ashley House | Kate Minion | HR Director | Buy | 37,000 | 459,750 | |||||||
| Avesco | Graham Andrews | Director | Buy | 13,000 | 292,183 | |||||||
| Blur Group | David Sheriff | Deputy Chairman | Buy | 28,500 | 72,600 | 8 days after appointed as deputy chairman | ||||||
| Blur Group | Richard Bourne-Arton | Non-Executive | Buy | 32,051 | 432,381 | |||||||
| City of London Investment | Barry Olliff | CEO | Sold | 250,000 | 2.9 million | Week after reporting profit increase | ||||||
| Euromoney | John Orchard | Manager | Sold | 6,630 | Undisclosed | |||||||
| Fiske | Gerard Luchini | Compliance Director | Buy | 6,000 | 45,000 | |||||||
| Fulcrum Utility | Philip Holder | Chairman | Buy | 250,000 | 3 million | |||||||
| Hammerson | Jean-Philippe Mouton | Director | Sold | 27,831 | 221,936 | Same day as company reported jump in pretax profit | ||||||
| Helios Underwriting | Nigel Hanbury | CEO | Buy | 17,188 | 1.3 million | Same day as it acquired Nameco for GBP900,000 | ||||||
| Hogg Robinson | Paul Williams | Non-Executive Director | Buy | 50,000 | 100,000 | 6 days after saying it would meet market expectations for FY14 | ||||||
| Indivior | Cary Claiborne | CFO | Buy | 62,000 | 85,780 | 2 days after Indivior posted lower pretax profit in maiden results | ||||||
| Indivior | Debby Betz | Corporate Affairs Officer | Buy | 8,000 | 15,900 | On day Indivior posted lower pretax profit in maiden results | ||||||
| Indivior | Shaun Thaxter | CEO | Buy | 335,000 | 425,000 | 5 days after Indivior posted lower pretax profit in maiden results | ||||||
| IPPlus | William Catchpole | MD | Buy | 58,647 | 2.7 million | |||||||
| IPPlus | Stuart Gordon | CFO | Buy | 14,154 | 1 million | |||||||
| IPPlus | Geoffrey Forsyth | Director | Buy | 22,289 | 1.1 million | |||||||
| Marks & Spencer | Steve Rowe | Director of Food Division | Sold | 109,250 | 160,714 | Rowe sold 40% of his shareholding | ||||||
| Nature Group | Peter Snell | Non-Executive | Buy | 115,000 | 900,000 | |||||||
| Plastics Capital | Non-Executive | Andrew Walker | Buy | 118,771 | 210,646 | |||||||
| Qatar Investment Fund | Nicholas Wilson | Chairman | Buy | 9,500 | 50,000 | |||||||
| Redrow | Will Heath | Development Director | Sold | 13,316 | Nil | 8 days after doubling dividend & profit increase | ||||||
| Rio Tinto | Megan Clark | Non-Executive | Buy | 1,550 | 1,715 | |||||||
| Rolls Royce | David Smith | CFO | Buy | 2,226 | 2,376 | |||||||
| TyraTech | James Hill | Non-Executive | Buy | 50,000 | 1.2 million | |||||||
| Verona Pharma | Jan-Anders Karlsson | CEO | Buy | 1 million | 2.7 million | |||||||
| Vianet | James Dickson | Chairman | Buy | 10,545 | 25,000 | |||||||
| Workspace Group | Graham Clemett | CFO | Sold | 20,000 | 73,159 | |||||||
| Julia Clemett | Sold | 20,372 | ||||||||||
| Workspace Group | Angus Boag | Development Director | Sold | 80,000 | 311,206 | |||||||
| Claire Boag | Sold | 5,000 | ||||||||||
| Workspace Group | Chris Pieroni | Operations Director | Sold | 2,350 | 173,263 | |||||||
| Caroline Pieroni | Sold | 96,970 | ||||||||||
| *Note: A recent company event around the time of the dealing does not suggest the dealing took place because of that event. | ||||||||||||
| When a spouse or related party to a director buys shares, the resulting holding is the beneficial holding of the director | ||||||||||||
| Contact: +44 207 199 0340; newsroom@alliancenews.com; @AllNewsTeam | ||||||||||||
| Copyright 2015 Alliance News Limited. All Rights Reserved. | ||||||||||||
16 Jul 2014 17:09
TyraTech does head lice deals with Boots and Superdrug
Life science group TyraTech announced deals with British chemist chains for its head lice treatment and raised £3.5m in a share placing. TyraTech, which focuses on nature-derived insect and parasite control products, has secured listings for its Vamousse head lice products in Superdrug and Boots st
Read more